Heme oxygenase-1 expression in peripheral blood mononuclear cells correlates with disease activity in multiple sclerosis

Journal of Neuroimmunology

Volumn 261, Issue 1-2, 2013, Pages 82-86

  Fagone, Paolo ^a   Patti, Francesco ^a   Mangano, Katia ^a   Mammana, Santa ^a   Coco, Marinella ^a   Touil Boukoffa, Chafia ^b   Chikovani, Tinatin ^c   Di Marco, Roberto ^d   Nicoletti, Ferdinando ^a  

^a UNIVERSITY OF CATANIA   (Italy)

^b UNIVERSITY OF SCIENCES AND TECHNOLOGY HOUARI BOUMEDIENE   (Algeria)

^c Tbilisi 1st Hospital University Clinic

^d UNIVERSITY OF MOLISE   (Italy)

Author keywords

Autoimmunity; HO 1; IFN beta; Multiple sclerosis

Indexed keywords

BETA1A INTERFERON; BILIVERDIN; CARBON MONOXIDE; HEME; HEME OXYGENASE 1; IRON; MESSENGER RNA; METHYLPREDNISOLONE;

ADULT; ARTICLE; CELL ISOLATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ACTIVITY; DISEASE EXACERBATION; DOWN REGULATION; FEMALE; HUMAN; HUMAN CELL; IMMUNOREGULATION; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; MULTIPLE SCLEROSIS; NUCLEOTIDE SEQUENCE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

AUTOIMMUNITY; HO-1; IFN-BETA; MULTIPLE SCLEROSIS;

ADULT; DISEASE PROGRESSION; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HEME OXYGENASE-1; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS;

EID: 84884413477     PISSN: 01655728     EISSN: 18728421     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2013.04.013     Document Type: Article

References (32)

1. Blancou P., Tardif V., Simon T., Rémy S., Carreño L., Kalergis A., Anegon I. Immunoregulatory properties of heme oxygenase-1. Methods Mol. Biol. 2011, 677:247-268.
2. Brusko T.M., Wasserfall C.H., Agarwal A., Kapturczak M.H., Atkinson M.A. An integral role for heme oxygenase-1 and carbon monoxide in maintaining peripheral tolerance by CD4+CD25+ regulatory T cells. J. Immunol. 2005, 174:5181-5186.
3. Chora A.A., Fontoura P., Cunha A., Pais T.F., Cardoso S., Ho P.P., Lee L.Y., Sobel R.A., Steinman L., Soares M.P. Heme oxygenase-1 and carbon monoxide suppress autoimmune neuroinflammation. J. Clin. Invest. 2007, 117:438-447.
4. Comabella M., Lunemann J.D., Rio J., Sanch ez A., Lopez C., Julia E., Fernandez M., Nonell L., Camina-Tato M., Deisenhammer F., Caballero E., Tortola M.T., Prinz M., Montalban X., Martin R. A type I interferon signature in monocytes is associated with poor response to interferon-beta in multiple sclerosis. Brain 2009, 132:3353-3365.
5. Denkinger C.M., Denkinger M., Kort J.J., Metz C., Forsthuber T.G. In vivo blockade of macrophage migration inhibitory factor ameliorates acute experimental autoimmune encephalomyelitis by impairing the homing of encephalitogenic T cells to the central nervous system. J. Immunol. 2003, 170:1274-1282.
6. Emerson M.R., LeVine S.M. Heme oxygenase-1 and NADPH cytochrome P450 reductase expression in experimental allergic encephalomyelitis: an expanded view of the stress response. J. Neurochem. 2000, 75:2555-2562.
7. Fagone P., Mangano K., Quattrocchi C., Motterlini R., Di Marco R., Magro G., Penacho N., Romao C.C., Nicoletti F. Prevention of clinical and histological signs of proteolipid protein (PLP)-induced experimental allergic encephalomyelitis (EAE) in mice by the water-soluble carbon monoxide-releasing molecule (CORM)-A1. Clin. Exp. Immunol. 2011, 163:368-374.
8. Fagone P., Mangano K., Coco M., Perciavalle V., Garotta G., Romao C.C., Nicoletti F. Therapeutic potential of carbon monoxide in multiple sclerosis. Clin. Exp. Immunol. 2012, 167:179-187.
9. Frisullo G., Nociti V., Iorio R., Patanella A.K., Marti A., Caggiula M., Mirabella M., Tonali P.A., Batocchi A.P. IL17 and IFNgamma production by peripheral blood mononuclear cells from clinically isolated syndrome to secondary progressive multiple sclerosis. Cytokine 2008, 44:22-25.
10. Frohman E.M., Racke M.K., Raine C.S. Multiple sclerosis-the plaque and its pathogenesis. N. Engl. J. Med. 2006, 354:942-955.
11. George J.F., Braun A., Brusko T.M., Joseph R., Bolisetty S., Wasserfall C.H., Atkinson M.A., Agarwal A., Kapturczak M.H. Suppression by CD4+CD25+ regulatory T cells is dependent on expression of heme oxygenase-1 in antigen-presenting cells. Am. J. Pathol. 2008, 173:154-160.
12. Ghoreschi K., Brück J., Kellerer C., Deng C., Peng H., Rothfuss O., Hussain R.Z., Gocke A.R., Respamm A., Glocovam I., Valtcheva N., Alexander E., Feil S., Feil R., Schulze-Osthoff K., Rupec R.A., Lovett-Racke A.E., Dringen R., Racke M.K., Röcken M. Fumarates improve psoriasis and multiple sclerosis by inducing type II dendritic cells. J. Exp. Med. 2011, 24:2291-2303.
13. Hagman S., Raunio M., Rossi M., Dastidar P., Elovaara I. Disease-associated inflammatory biomarker profiles in blood in different subtypes of multiple sclerosis: prospective clinical and MRI follow-up study. J. Neuroimmunol. 2011, 234:141-147.
14. Hecker M., Goertsches R.H., Fatum C., Koczan D., Thiesen H.J., Guthke R., Zettl U.K. Network analysis of transcriptional regulation in response to intramuscular interferon-β-1a multiple sclerosis treatment. Pharmacogenomics J. 2012, 12:134-146.
15. Kemppinen A.K., Kaprio J., Palotie A., Saarela J. Systematic review of genome-wide expression studies in multiple sclerosis. BMJ Open 2011, 1:e000053.
16. Kohm A.P., Carpentier P.A., Anger H.A., Miller S.D. Cutting edge: CD4+CD25+ regulatory T cells suppress antigen-specific autoreactive immune responses and central nervous system inflammation during active experimental autoimmune encephalomyelitis. J. Immunol. 2002, 169:4712-4716.
17. Lee T.S., Chau L.Y. Heme oxygenase-1 mediates the anti-inflammatory effect of interleukin-10 in mice. Nat. Med. 2002, 8:240-246.
18. Lindsey J.W., Agarwal S.K., Tan F.K. Gene expression changes in multiple sclerosis relapse suggest activation of T and non-T cells. Mol. Med. 2011, 17:95-102.
19. Liu Y., Zhu B., Luo L., Li P., Paty D.W., Cynader M.S. Heme oxygenase-1 plays an important protective role in experimental autoimmune encephalomyelitis. Neuroreport. 2001, 12:1841-1845.
20. Loma I., Heyman R. Multiple sclerosis: pathogenesis and treatment. Curr. Neuropharmacol. 2011, 9:409-416.
21. Mehindate K., Sahlas D.J., Frankel D., Mawal Y., Liberman A., Corcos J., Dion S., Schipper H.M. Proinflammatory cytokines promote glial heme oxygenase-1 expression and mitochondrial iron deposition: implications for multiple sclerosis. J. Neurochem. 2001, 77:1386-1395.
22. Motterlini R., Otterbein L.E. The therapeutic potential of carbon monoxide. Nat. Rev. Drug Discov. 2010, 9:728-743.
23. Nicoletti F., Patti F., Cocuzza C., Zaccone P., Nicoletti A., Di Marco R., Reggio A. Elevated serum levels of interleukin-12 in chronic progressive multiple sclerosis. J. Neuroimmunol. 1996, 70:87-90.
24. Nicoletti F., Patti F., Di Marco R., Zaccone P., Nicoletti A., Meroni P., Reggio A. Circulating serum levels of IL-1ra in patients with relapsing remitting multiple sclerosis are normal during remission phases but significantly increased either during exacerbations or in response to IFN-beta treatment. Cytokine 1996, 8:395-400.
25. Nicoletti F., Di Marco R., Patti F., Reggio E., Nicoletti A., Zaccone P., Stivala F., Meroni P.L., Reggio A. Blood levels of transforming growth factor-beta 1 (TGF-beta1) are elevated in both relapsing remitting and chronic progressive multiple sclerosis (MS) patients and are further augmented by treatment with interferon-beta 1b (IFN-beta1b). Clin. Exp. Immunol. 1998, 113:96-99.
26. Nicoletti F., Di Marco R., Mangano K., Patti F., Reggio E., Nicoletti A., Bendtzen K., Reggio A. Increased serum levels of interleukin-18 in patients with multiple sclerosis. Neurology 2001, 57:342-344.
27. Pae H.O., Oh G.S., Choi B.M., Chae S.C., Chung H.T. Differential expressions of heme oxygenase-1 gene in CD25+ and CD25- subsets of human CD4+ T cells. Biochem. Biophys. Res. Commun. 2003, 306:701-705.
28. Powell N.D., Papenfuss T.L., McClain M.A., Gienapp I.E., Shawler T.M., Satoskar A.R., Whitacre C.C. Cutting edge: macrophage migration inhibitory factor is necessary for progression of experimental autoimmune encephalomyelitis. J. Immunol. 2005, 175:5611-5614.
29. Schipper H.M. Heme oxygenase expression in human central nervous system disorders. Free Radic. Biol. Med. 2004, 37:1995-2011.
30. Schluesener H.J., Seid K. Heme oxygenase-1 in lesions of rat experimental autoimmune encephalomyelitis and neuritis. J. Neuroimmunol. 2000, 110:114-120.
31. Tzima S., Victoratos P., Kranidioti K., Alexiou M., Kollias G. Myeloid heme oxygenase-1 regulates innate immunity and autoimmunity by modulating IFN-beta production. J. Exp. Med. 2009, 206:1167-1179.
32. Yamazaki H., Ohta K., Tsukiji H., Toma T., Hashida Y., Ishizaki A., Saito T., Arai S., Koizumi S., Yachie A. Corticosteroid enhances heme oxygenase-1 production by circulating monocytes by up-regulating hemoglobin scavenger receptor and amplifying the receptor-mediated uptake of hemoglobin-haptoglobin complex. Biochem. Biophys. Res. Commun. 2007, 358:506-512.